🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/1973 | 0,0093 USD |
| 31/08/1973 | 0,0078 USD |
| 05/06/1973 | 0,0078 USD |
| 05/03/1973 | 0,0078 USD |
| 05/12/1972 | 0,0078 USD |
| 09/06/1972 | 0,0073 USD |
| 02/03/1972 | 0,0073 USD |
| 06/12/1971 | 0,0073 USD |
| 03/09/1971 | 0,0073 USD |
| 07/06/1971 | 0,0073 USD |
| 02/03/1971 | 0,0073 USD |
| 01/12/1970 | 0,0073 USD |
| 02/09/1970 | 0,0066 USD |
| 02/06/1970 | 0,0066 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/10/1983 | 2,66 | 2,68 | 2,65 | 2,67 | -1,10% | 0,99% | 3.855.802 |
| 21/10/1983 | 2,67 | 2,70 | 2,65 | 2,70 | +0,74% | 1,73% | 11.031.667 |
| 20/10/1983 | 2,68 | 2,69 | 2,66 | 2,68 | +0,13% | 1,24% | 10.937.347 |
| 19/10/1983 | 2,71 | 2,71 | 2,64 | 2,67 | -1,47% | 2,69% | 8.937.763 |
| 18/10/1983 | 2,77 | 2,77 | 2,71 | 2,71 | -1,80% | 2,04% | 4.723.546 |
| 17/10/1983 | 2,76 | 2,77 | 2,75 | 2,76 | +0,97% | 0,96% | 7.375.824 |
| 14/10/1983 | 2,70 | 2,75 | 2,70 | 2,74 | +1,97% | 1,97% | 4.549.997 |
| 13/10/1983 | 2,66 | 2,70 | 2,65 | 2,68 | +1,25% | 1,87% | 3.889.757 |
| 12/10/1983 | 2,65 | 2,70 | 2,64 | 2,65 | -0,25% | 2,12% | 6.010.070 |
| 11/10/1983 | 2,71 | 2,72 | 2,66 | 2,66 | -2,55% | 2,20% | 7.515.418 |
| 10/10/1983 | 2,70 | 2,73 | 2,67 | 2,73 | +0,86% | 2,09% | 2.505.139 |
| 07/10/1983 | 2,72 | 2,74 | 2,67 | 2,70 | +0,62% | 2,68% | 17.883.072 |
| 06/10/1983 | 2,65 | 2,70 | 2,64 | 2,69 | +1,37% | 2,25% | 11.873.002 |
| 05/10/1983 | 2,59 | 2,65 | 2,59 | 2,65 | +1,91% | 2,43% | 7.572.010 |
| 04/10/1983 | 2,58 | 2,61 | 2,57 | 2,60 | +0,90% | 1,42% | 7.017.408 |
| 03/10/1983 | 2,54 | 2,58 | 2,54 | 2,58 | +0,78% | 1,82% | 3.410.611 |
| 30/09/1983 | 2,55 | 2,57 | 2,55 | 2,56 | +0,00% | 0,65% | 3.210.653 |
| 29/09/1983 | 2,56 | 2,56 | 2,55 | 2,56 | +0,26% | 0,65% | 4.199.126 |
| 28/09/1983 | 2,55 | 2,55 | 2,53 | 2,55 | +0,26% | 0,91% | 2.512.685 |
| 27/09/1983 | 2,57 | 2,57 | 2,54 | 2,54 | -1,92% | 1,42% | 7.428.643 |
| 26/09/1983 | 2,52 | 2,60 | 2,52 | 2,59 | +3,16% | 3,02% | 6.851.405 |
| 23/09/1983 | 2,52 | 2,52 | 2,50 | 2,51 | -0,13% | 0,79% | 9.084.902 |
| 22/09/1983 | 2,50 | 2,52 | 2,49 | 2,52 | +0,80% | 1,06% | 7.937.971 |
| 21/09/1983 | 2,52 | 2,52 | 2,48 | 2,50 | -0,40% | 1,45% | 7.824.787 |
| 20/09/1983 | 2,48 | 2,52 | 2,48 | 2,51 | +1,07% | 1,74% | 8.141.702 |
| 19/09/1983 | 2,44 | 2,49 | 2,44 | 2,48 | +1,49% | 2,17% | 4.504.723 |
| 16/09/1983 | 2,41 | 2,46 | 2,40 | 2,45 | +1,93% | 2,48% | 5.632.790 |
| 15/09/1983 | 2,44 | 2,44 | 2,40 | 2,40 | -1,90% | 1,77% | 1.746.806 |
| 14/09/1983 | 2,43 | 2,45 | 2,43 | 2,45 | +1,10% | 0,68% | 2.139.178 |
| 13/09/1983 | 2,39 | 2,42 | 2,39 | 2,42 | +0,41% | 1,38% | 2.912.602 |